(Q34786793)

4 August 2017

1 reference

title

Depression in Alzheimer's disease: overview and treatment (English)

1 reference

4 August 2017

0 references

Constantine G. Lyketsos

series ordinal

1

object named as

Constantine G Lyketsos

1 reference

4 August 2017

Jason Olin

2

1 reference

PubMed ID

12182930

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

4 August 2017

Biological Psychiatry

1 reference

4 August 2017

52

1 reference

4 August 2017

3

1 reference

4 August 2017

243-252

1 reference

Insight in Alzheimer's patients: results of a longitudinal study using three assessment methods.

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Psychiatric phenomena in Alzheimer's disease. I: Disorders of thought content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Psychiatric phenomena in Alzheimer's disease. II: Disorders of perception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Psychiatric phenomena in Alzheimer's disease. III: Disorders of mood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Psychiatric phenomena in Alzheimer's disease. IV: Disorders of behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Insight for impairment in independent living skills in Alzheimer's disease and multi-infarct dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

The course of psychopathologic features in mild to moderate Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

The stress and psychological morbidity of the Alzheimer patient caregiver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Quality of life in dementia patients in long-term care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Association between premorbid history of depression and current depression in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Two-Year Survival in Patients With Mixed Symptoms of Depression and Cognitive Impairment: Comparison With Major Depression and Primary Degenerative Dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

A double-blind comparison of the efficacy and safely of paroxetine and imipramine in the treatment of depression with dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Characteristics and outcomes of dementia residents in an assisted living facility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Major and minor depression in Alzheimer's disease: prevalence and impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Physical aggression in dementia patients and its relationship to depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Major depression in Alzheimer's disease. An interaction between gender and family history.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

The spectrum of behavioral changes in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Depression among institutionalized aged: assessment and prevalence estimation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Relationship of cognitive and functional impairment to depressive features in Alzheimer's disease and other dementias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Incidence, prevalence, and outcomes of depression in residents of a long-term care facility with dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Delusions in Alzheimer's disease: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

The benefits and risks of ECT for patients with primary dementia who also suffer from depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Double-blind trial of imipramine in Alzheimer's disease patients with and without depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Suicide and Alzheimer's pathology in the elderly: a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

A metaanalysis of controlled trials of neuroleptic treatment in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

The incidence of mental and behavioral disturbances in dementia: the cache county study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Efficacy and tolerability of carbamazepine for agitation and aggression in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Behavioral treatment of depression in dementia patients: a controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

A reevaluation of the duration of survival after the onset of dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Neuropathologic and neurochemical correlates of psychosis in primary dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

The neuropathology of aminergic nuclei in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

Clinical and neuropathological correlates of depression in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Impaired awareness of deficits in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901348-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(02)01348-3

1 reference

4 August 2017

1 reference

PubMed ID

12182930